By David Dieterich – I recently attended the first Strategic Health Information Exchange Collaborative (SHIEC) annual meeting in Deer Valley, Utah. If you are not familiar with this group, it’s a group of regional or state HIEs that formed a collaborative late last year.
Read More
By William Hersh MD – Like many academic health science centers, my institution is undergoing a planning process to determine our strategy for data science. I have expressed my concern about the (lack of?) differences between data science and biomedical and health informatics, but the former term seems to be carrying the day.
By David McCready – There is a growing interest among many hospitals to migrate toward alternative service delivery models referred to as “service lines.” The concept with clinical service lines is to shift the hospital’s care delivery model from the traditional specialty silos to a more horizontal organizational structure.
By Kerri Knippenberg – Digital health has seen huge growth in 2015 for B2C markets. We have all seen the growth of telemedicine, but that is not the only digital health market to have greatly expanded. Genetic services, mobile health tracking and online physician reviews have all seen growth in the past year.
By John Halamka MD – Just as I summarized the CMS Meaningful Use Final Rule last week, this week I’ll summarize the 560 pages of the ONC 2015 Certification Final Rule. Key points to understanding the rule include:
By Art Gross – The practice of medicine is a risky business. There is always the risk that a certain treatment will fail to help a patient. There is a risk of being accused of malpractice. There is a risk of being accused of incorrectly billing a patient, insurance company or government agency.
By Gajen Sunthara – For the past year, I have been honored to serve my country as a Presidential Innovation Fellow (PIF) with the ONC. As my PIF journey comes to an end, I wanted to provide a brief recap of my work and its potential for the future.
By Matt Fisher – National Health IT Week was a busy time with regard to government announcements. First, the final rule for Meaningful Use Stage 3 and Modifications was released and second, on the same day, the OIG released a reminder about information blocking concerns.
By Nina L. Hunter PhD & Robert M. Califf MD – We recently announced the first FDA Patient Engagement Advisory Committee (PEAC), supported by the Center of Devices and Radiological Health (CDRH). The Committee will provide advice to the FDA Commissioner on complex issues relating to medical devices, the regulation of devices, and their use by patients.